Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in

Jee Hee Yoo1,2, Sung Woon Park1, Ji Eun Jun3

  • 1Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Insights

Low skeletal muscle mass and sarcopenic obesity are linked to diastolic dysfunction in adults. This highlights the importance of body composition in heart health, particularly in older populations.

Area of Science:

  • Cardiology
  • Geriatrics
  • Nutritional Science

Background:

  • Heart failure with preserved ejection fraction (HFpEF) is a growing global health concern, exacerbated by an aging population.
  • The relationship between low skeletal muscle mass, sarcopenic obesity, and left ventricular diastolic dysfunction is not well understood.
  • Investigating these associations is crucial for understanding HFpEF development.

Purpose of the Study:

  • To examine the association between low skeletal muscle mass, sarcopenic obesity, and diastolic dysfunction.
  • To analyze these relationships in a large cohort of Korean adults.
  • To provide insights into the pathophysiology of diastolic dysfunction in aging populations.

Main Methods:

  • A cross-sectional study involving 31,258 adults who underwent health examinations.
  • Skeletal muscle mass was quantified using the skeletal muscle mass index (SMI) via bioelectrical impedance analysis.
  • Echocardiography was employed to assess cardiac structure and function, specifically left ventricular diastolic function.

Main Results:

  • Diastolic dysfunction was identified in 9.78% of the study cohort.
  • Lower SMI tertiles were significantly associated with increased odds of diastolic dysfunction (OR: 1.56).
  • Sarcopenic obesity showed the highest risk for diastolic dysfunction (OR: 1.70), followed by obesity-only and sarcopenia-only.

Conclusions:

  • Reduced skeletal muscle mass and sarcopenic obesity are significantly associated with diastolic dysfunction.
  • These findings are consistent in both middle-aged and elderly populations (age ≥ 65 years).
  • Body composition, including muscle mass and obesity, plays a critical role in diastolic dysfunction.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
337
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
263
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
319
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
383